Taking everything into account, CERS scores 3 out of 10 in our fundamental rating. CERS was compared to 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of CERS have multiple concerns. CERS is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

CERS had negative earnings in the past year.
In the past year CERS had a positive cash flow from operations.
CERS had negative earnings in each of the past 5 years.
In the past 5 years CERS reported 4 times negative operating cash flow.

1.2 Ratios

CERS has a better Return On Assets (-7.42%) than 65.05% of its industry peers.
With a Return On Equity value of -25.97%, CERS perfoms like the industry average, outperforming 59.14% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-7.42%
ROE	-25.97%
ROIC	N/A

ROA(3y)-16.33%

ROA(5y)-19.79%

ROE(3y)-57.26%

ROE(5y)-58.76%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 60.50%, CERS is doing good in the industry, outperforming 62.37% of the companies in the same industry.
CERS's Gross Margin has been stable in the last couple of years.
CERS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	60.5%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.16%

GM growth 5Y-1.44%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CERS does not have a ROIC to compare to the WACC, probably because it is not profitable.
CERS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CERS has been increased compared to 5 years ago.
CERS has a worse debt/assets ratio than last year.

2.2 Solvency

CERS has an Altman-Z score of -3.71. This is a bad value and indicates that CERS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.71, CERS is doing worse than 66.67% of the companies in the same industry.
The Debt to FCF ratio of CERS is 505.38, which is on the high side as it means it would take CERS, 505.38 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 505.38, CERS is in the better half of the industry, outperforming 66.13% of the companies in the same industry.
A Debt/Equity ratio of 0.79 indicates that CERS is somewhat dependend on debt financing.
The Debt to Equity ratio of CERS (0.79) is worse than 71.51% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.79
Debt/FCF	505.38
Altman-Z	-3.71

ROIC/WACCN/A

WACC10.53%

2.3 Liquidity

CERS has a Current Ratio of 1.89. This is a normal value and indicates that CERS is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.89, CERS is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
CERS has a Quick Ratio of 1.29. This is a normal value and indicates that CERS is financially healthy and should not expect problems in meeting its short term obligations.
CERS's Quick ratio of 1.29 is on the low side compared to the rest of the industry. CERS is outperformed by 65.05% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.89
Quick Ratio	1.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.27% over the past year.
The Revenue has grown by 14.18% in the past year. This is quite good.
Measured over the past years, CERS shows a quite strong growth in Revenue. The Revenue has been growing by 16.50% on average per year.

EPS 1Y (TTM)27.27%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)14.18%

Revenue growth 3Y8.07%

Revenue growth 5Y16.5%

Sales Q2Q%14.52%

3.2 Future

CERS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.91% yearly.
Based on estimates for the next years, CERS will show a quite strong growth in Revenue. The Revenue will grow by 14.35% on average per year.

EPS Next Y25.82%

EPS Next 2Y27.64%

EPS Next 3Y27.91%

EPS Next 5YN/A

Revenue Next Year24.59%

Revenue Next 2Y16.8%

Revenue Next 3Y14.35%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CERS. In the last year negative earnings were reported.
Also next year CERS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CERS indicates a somewhat cheap valuation: CERS is cheaper than 66.13% of the companies listed in the same industry.